Skip to main content

IBEX Ltd

For the period ended Mar 31, 2025. Filed May 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 8, 2025

IBEX$52.23+3.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Stockholders' Equity (unaudited)

Consolidated Statements of Stockholders’ Equity

(in thousands)

Three months ended March 31, 2024 and 2025 · Common shares · TreasuryStock · AdditionalPaid-inCapital · Accumulated OtherComprehensiveIncome / (Loss) · AccumulatedDeficit · TotalStockholders'Equity
Shares · Amount · Amount
Balance, December 31, 202317,681$2$(14,116)$207,638$(6,133)$(31,278)$156,113
Net income—————10,31010,310
Foreign currency translation adjustment————(288)—(288)
Changes in fair value of cash flow hedges————(131)—(131)
Purchase of treasury shares(502)—(8,117)———(8,117)
Provision for common stock warrants———299——299
Issuance of common shares35——351——351
Share-based compensation expense———774——774
Balance, March 31, 202417,214$2$(22,233)$209,062$(6,552)$(20,968)$159,311
Common shares · TreasuryStock · AdditionalPaid-inCapital · Accumulated OtherComprehensiveIncome / (Loss) · Retained Earnings · TotalStockholders'Equity
Shares · Amount · Amount
Balance, December 31, 202413,182$1$(101,606)$212,116$(7,250)$5,676$108,937
Net income—————10,46910,469
Foreign currency translation adjustment————374—374
Changes in fair value of cash flow hedges————385—385
Purchase of treasury shares——(52)———(52)
Issuance of common shares190——2,809——2,809
Share-based compensation expense———1,259——1,259
Balance, March 31, 202513,372$1$(101,658)$216,184$(6,491)$16,145$124,181
Nine months ended March 31, 2024 and 2025 · Common shares · TreasuryStock · AdditionalPaid-inCapital · Accumulated OtherComprehensiveIncome / (Loss) · AccumulatedDeficit · TotalStockholders'Equity
Shares · Amount · Amount
Balance, June 30, 202318,280$2$(3,682)$204,734$(6,312)$(44,778)$149,964
Net income—————23,81023,810
Foreign currency translation adjustment————(310)—(310)
Changes in fair value of cash flow hedges————70—70
Purchase of treasury shares(1,125)—(18,551)———(18,551)
Provision for common stock warrants———893——893
Issuance of common shares59——362——362
Share-based compensation expense———3,073——3,073
Balance, March 31, 202417,214$2$(22,233)$209,062$(6,552)$(20,968)$159,311
Common shares · TreasuryStock · AdditionalPaid-inCapital · Accumulated OtherComprehensiveIncome / (Loss) · Retained Earnings / (Deficit) · TotalStockholders'Equity
Shares · Amount · Amount
Balance, June 30, 202417,017$2$(25,367)$210,200$(7,913)$(11,123)$165,799
Net income—————27,26827,268
Foreign currency translation adjustment————851—851
Changes in fair value of cash flow hedges————571—571
Purchase of treasury shares(3,890)(1)(76,291)———(76,292)
Issuance of common shares245——3,534——3,534
Share-based compensation expense———2,450——2,450
Balance, March 31, 202513,372$1$(101,658)$216,184$(6,491)$16,145$124,181
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.